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Abstract
Background: The work presented here investigates parallel imaging applied to T1-weighted high
resolution imaging for use in longitudinal volumetric clinical studies involving Alzheimer's disease
(AD) and Mild Cognitive Impairment (MCI) patients. This was in an effort to shorten acquisition
times to minimise the risk of motion artefacts caused by patient discomfort and disorientation. The
principle question is, "Can parallel imaging be used to acquire images at 1.5 T of sufficient quality
to allow volumetric analysis of patient brains?"
Methods: Optimisation studies were performed on a young healthy volunteer and the selected
protocol (including the use of two different parallel imaging acceleration factors) was then tested
on a cohort of 15 elderly volunteers including MCI and AD patients. In addition to automatic brain
segmentation, hippocampus volumes were manually outlined and measured in all patients. The 15
patients were scanned on a second occasion approximately one week later using the same protocol
and evaluated in the same manner to test repeatability of measurement using images acquired with
the GRAPPA parallel imaging technique applied to the MPRAGE sequence.
Results:  Intraclass correlation tests show that almost perfect agreement between repeated
measurements of both segmented brain parenchyma fraction and regional measurement of
hippocampi. The protocol is suitable for both global and regional volumetric measurement
dementia patients.
Conclusion:  In summary, these results indicate that parallel imaging can be used without
detrimental effect to brain tissue segmentation and volumetric measurement and should be
considered for both clinical and research studies where longitudinal measurements of brain tissue
volumes are of interest.
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Background
Age is the strongest predicting factor for dementia. In
total, dementia affects more than 25% of those aged over
85 years and between 30 and 50% of those aged over 90
years. Due to the population boom of the 1940's the eld-
erly population is rapidly growing. Thus, the prevalence of
dementia is expected to increase significantly over the
coming decades. Rapid diagnosis and treatment is there-
fore of evermore-importance.
One of the most widely accepted imaging biomarkers in
the aging process is that of brain tissue atrophy and an
increase in cerebral spinal fluid (CSF) volume. Much
effort is put into correlating rates of brain atrophy with
disease progression [1,2]in order that the imaging may be
used as a diagnostic tool [3] rather than depending on
mental ability tests only. As yet, there is no cure or clini-
cally available vaccine for Alzheimer's disease (AD) but
the rate of disease progression may be reduced if medica-
tion is started at an early stage. One target group of
patients for disease modifying drugs are those in the early
stages of AD [4]. It has been previously reported [5] that a
decline in brain parenchyma volume (a rate above that of
healthy elderly) is seen before the diagnosis of AD can be
made. Thus, it may prove invaluable to identify those per-
sons prior to the onset of clinical AD symptoms.
In the case of longitudinal studies involving dementia
patients, small volume changes in the brain parenchyma
fraction (BPF) or in regional grey matter (GM) are of sig-
nificance. Expected BPF changes of less than 1% demands
that the repeatability in measurement is excellent. In order
to interpret the measured volume changes as significant
the error in repeated measurement must be very small
indeed. This requires that exceptional image quality be
achieved on multiple occasions, which may coincide with
large changes in patient cognition. The first challenge is
therefore to ensure that the repeated protocol is suitable
for patients who may not be entirely cooperative or be
unable to follow instructions. Short imaging times would
therefore be of particular interest.
After successful acquisition of the 3-dimentional data,
volumetric analysis must then be performed, which is an
intricate method subject to several sources of error. Brain
segmentation methods rely on the ability to classify cor-
rectly the contents of a voxel as one of three tissue classes:
CSF, GM or white matter (WM). Partial volume effects are
likely the most significant source of error in segmentation
and can be attributed to several factors. Firstly, low image
resolution leads to an inherent partial volume increase
and secondly, slight patient motion will increase the par-
tial volume. (Significant patient motion will cause more
severe artefacts rendering the images unsuitable for volu-
metric analysis.) To minimise partial volume effects, the
smallest measurable volume, i.e. the voxel, should be as
small as possible.
Thus, the imaging protocol requirements for successful
longitudinal imaging of dementia patients can be consid-
ered as having a high resolution (small voxel) and short
acquisition time (AT).
Unfortunately, increasing the resolution requires a longer
acquisition time in discord with the first goal of shorter
acquisition time. However, parallel imaging techniques
such as GRAPPA and SENSE [6-8] are now commonly
available on clinical MRI scanners using phased array coils
for data acquisition. The techniques under-sample k-space
and use sensitivity maps of each coil element to predict
the signals in missing k-space lines. Thus an acceleration
of the acquisition is performed allowing high resolution
acquisitions in shorter periods of time (or higher resolu-
tion acquisitions in a given AT).
Of course, there is a cost to using parallel imaging and that
is a decreased signal to noise ratio (SNR). Since tissue seg-
mentation methods rely on classifying a voxels signal
intensity to one of several classes, it is assumed that a
decreased SNR reduces the accuracy of volumetric tissue
segmentation and to the authors knowledge has not been
applied to any longitudinal volumetric studies. Parallel
imaging was not, for example, implemented in the most
widely known imaging protocol of the Alzheimer's Dis-
ease Neuroimaging Initiative (ADNI) [9,10].
The purpose of this study was to test the roll of the
GRAPPA parallel imaging technique applied to T1-
weighted high resolution imaging intended for volumet-
ric analysis. A study was recently published looking at the
effect of SENSE parallel imaging applied to 3D T1-
weighted image acquisitions on Voxel-based Specific
Regional Analysis for Alzheimer's Disease (VSRAD). Very
little difference was found between the images acquired
with and without SENSE applied despite the reduced SNR
native to SENSE images. [11] Investigations were per-
formed on both young healthy and elderly volunteers
including AD as well as mild cognitively impaired (MCI)
patients. Global brain tissue volumes were repeatedly
measured in both young healthy volunteers and in the
elderly dementia groups.
The noise distribution in an image acquired with parallel
imaging is not uniformly distributed but is worse at the
centre of the imaging volume. Thus, the ability to quantify
volumes in the one of the most compromised regions was
also tested by measurement of hippocampus volumes in
dementia patients using manual outlining methods.BMC Medical Imaging 2009, 9:15 http://www.biomedcentral.com/1471-2342/9/15
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Methods
Magnetic resonance imaging
A 1.5 T Avanto (Siemens Healthcare, Erlangen, Germany)
scanner equipped with a 12-channel phased array matrix
coil were used in this study. It was decided that a complete
3D imaging protocol was most suitable since it allows
high SNR and high resolution in all three directions for
each sequence. The 3D data sets were all acquired in the
sagital direction. This minimised acquisition time due to
the dimensions of the head.
A cubic voxel (1.3 × 1.3 × 1.3 mm) was set since this ena-
bles the images to be re-sliced in any of the three major
planes without compromising resolution. Volumetric
evaluation of small brain structures such as the hippocam-
pus, which is commonly performed in the coronal orien-
tation, could easily be performed after re-slicing the
images.
The 3D protocol comprised of Siemens 3D T1-weighted
MPRAGE, 3D- FLAIR and 3D T2-weighted SPACE
sequences. All three sequences were acquired using the
GRAPPA parallel imaging technique [6]. The FLAIR
sequence was intended for use in the clinical protocol
only and was not used in the brain segmentation process.
The influence of GRAPPA applied to the MPRAGE
sequence in particular was investigated since the resulting
3D data are most commonly used for brain tissue segmen-
tation. The MPRAGE sequence was defined with the same
imaging parameters as the ADNI MPRAGE sequence.
Table 1 includes the imaging parameters of each of the
sequences used in this volumetric study. The MPRAGE
sequence takes 7 minute 42 seconds for a typical brain
acquired in the sagital orientation without GRAPPA. The
same sequence acquired with acceleration factor two takes
4 minutes 21 seconds and with acceleration factor four
takes 2 minutes 40 seconds. The GRAPPA technique
makes use of 24 extra lines of data sampled in the centre
of k-space to correct for the missing data throughout k-
space thereby maintaining much of the contrast informa-
tion. Due to the overall under-sampling of k-space, the
SNR throughout the image is nevertheless reduced.
Table 1: Imaging parameters of volumetric sequences.
Sequence name MPRAGE MPRAGE SPACE
Orientation Sagittal Sagittal Sagittal
TR (ms) 2400 2400 3200
TE (ms) 3.44 3.44 434
TI (ms) 1000 1000 -
Flip angle (degrees) 8 8 Variable T2W
Slice width (mm) 1.3 1.3 1.3
No. Slices per slab 128 128 128
Slice separation (%) 50 50
T F --1 0 7
Matrix (PE, FE) 192 × 192 192 × 192 192 × 192
FOV (mm) 250 250 250
Phase encoding direction Anterior-posterior Anterior-posterior Anterior-posterior
Bandwidth (Hz/Px) 150 150 704
i P A T 242
Total scan time (min:s) 4:21 2:40 3:22
The key imaging parameters are shown for the MPRAGE with iPAT acceleration factors 2 and 4 as well as the SPACE sequence.BMC Medical Imaging 2009, 9:15 http://www.biomedcentral.com/1471-2342/9/15
Page 4 of 10
(page number not for citation purposes)
Healthy young volunteer
To investigate the repeatability of the scanning-segmenta-
tion process a volunteer was repeatedly scanned using the
MPRAGE sequence at different parallel imaging accelera-
tion factors. The SPACE sequence was also acquired. The
volunteer was scanned 18 times: Six times without paral-
lel imaging, six times with acceleration factor two and six
times with acceleration factor four. This scanning was
divided into 2 scan sessions within a period of a week.
Each scan session was approximately 1 hour in duration
and included 3 acquisitions at each parallel imaging fac-
tor. Between every scan, the volunteer was removed from
the scanner and asked to walk around the room. This
ensured that the B1 field inhomogeneity would vary
between scans, as would be the case in a longitudinal
study.
Elderly patient group
This clinical study was designed to test the complete pro-
tocol on elderly patients whose brains have different anat-
omy and signal intensity distributions to healthy young
volunteers. 15 age-matched elderly patients were recruited
through the hospital's Memory Clinic: four patients clini-
cally diagnosed with AD (mean age 70 years; standard
deviation 6 years), four MCI patients (mean age 67 years,
standard deviation 5 years) and seven healthy elderly
patients (mean age 74 years; standard deviation 8 years).
The healthy elderly and AD patients were diagnosed using
the DSM-IV criteria and MCI patients were defined as sub-
jects investigated for suspected dementia, with cognitive
impairment not severe enough to fulfill the criteria for
AD.
The 3D protocol (MPRAGE, SPACE and FLAIR sequences)
was followed on all 15 patients. The MPRAGE sequences
were acquired with acceleration factor two and accelera-
tion factor four in addition to a 3D T2-weighted SPACE
sequence. The volumetric acquisition time was approxi-
mately 13 minutes in total.
To test the repeatability of the protocol the elderly group
was scanned on a second occasion one week after the first
using the same imaging protocol. (Two MCI patients were
unintentionally not scanned using acceleration factor four
on the second scan occasion).
Approval from the hospital's local ethics committee to
perform this project was obtained before commencement
of any volunteer or patient scanning. Informed consent
was obtained from each volunteer and patient prior to
entering the study.
Image processing
Investigating the use of parallel imaging for use in longi-
tudinal volumetric studies must take account of the post
processing stages and not simply the acquisition. Thus,
two evaluation techniques were used for automatic seg-
mentation of the datasets to verify that the study is not
dependant on the post processing technique. No two eval-
uation software will produce the same segmented tissue
volumes [12] and so comparisons of the resulting brain
tissue volumes should not be made. However, the repeat-
ability in measurement for each method is the figure of
significance.
In-house software, BMAP/Volstat (Stockholm, Sweden)
developed for volumetric brain analysis was used in addi-
tion to the FSL software package (Oxford, UK) for whole
brain volume measurement. For summary description of
the two methods see table 2.
FSL [13] is a standard evaluation tool widely accepted for
use in volumetric brain tissue analysis. Image data are co-
registered to the FSL template brain, inhomogeneity cor-
rected and masked using the BET algorithm [14] (FSL,
Oxford, UK) to extract the brain. The data were finally
processed through the Sienax [15,16] algorithm (FSL,
Oxford, UK) to segment the data into three tissue classes:
CSF, GM and WM. The crisp volumes of these tissue
classes were output for analysis. In a crisp segmentation
each voxel is characterized by a single tissue type only.
There was some difficulty in masking the images in BET.
There was often a significant amount of leakage to tissue
outside the brain area as is recently reported [17]. The
masking was particularly poor around the orbital region
and base of the brain. However, this was solved with the
use of the co-registered T2- weighted 3D SPACE data,
which was masked without problem. The cortical GM –
CSF signal intensity difference is greater on T2-weighted
imaging, which is the likely cause of the more successful
masking. The resulting mask could be applied to the T1-
weighted images providing data of an extracted T1-
weighted brain for use in volumetric segmentation.
The in-house software is written on the HERMES (Hermes
Medical Solutions, Stockholm, Sweden) platform and
used to co-register [18], inhomogeneity correct, mask and
segment the 3D datasets. The program BMAP masks with
a different aim than the BET algorithm so that cortical CSF
is also included in the segmented volumes whereas the
BET program masks to the brain grey matter surface and
therefore only includes an internal CSF volume. The in-
house segmentation program called Volstat is based on a
fuzzy c means clustering (FCM) algorithm [19-21]. The
algorithm is enhanced by use of the distribution of signal
intensity specific to each tissue type. This is used as a
weighting factor in the iteration process to decide the tis-
sue composition of a voxel. Fuzzy volume maps as well as
crisp volume maps of each of the three tissue classes are
output from Volstat for further analysis. Volumes quoted
in this study are the fuzzy volumes and can therefore notBMC Medical Imaging 2009, 9:15 http://www.biomedcentral.com/1471-2342/9/15
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be compared to the more course crisp volumes output
from Sienax.
The HERMES MultiModality program was also used for
hippocampus volume measurement using a manual out-
lining technique. Analysis was performed using only
images acquired with acceleration factor two. A single
trained operator performed all measurements. The bor-
ders of both left and right hippocampi were delineated on
each image slice from posterior to anterior to generate a
series of regions of interest (ROIs). The first ROI was
drawn on the slice where crus of the fornix could be seen
in full profile. The measurements ended where the hip-
pocampus disappeared under the amygdala. The summed
volume of each ROI gave the hippocampus volume.
The complete evaluation of whole brain segmentation
and hippocampus volume measurement was performed
on data of each patient acquired on two separate occa-
sions.
Statistics
Analysis was performed with the Statistica statistical soft-
ware package (StatSoft Inc., Tulsa, OK, USA). The class 1
intraclass correlation test (ICC) [22,23] was used which is
typical test to measure the agreement between two data
sets with 1.0 indicating perfect agreement. According to
Landis and Koch [24] values greater than 0.81 indicate
almost perfect agreement.
Results
Healthy young volunteer
Figure 1 presents a series of images of a single volunteer
acquired without parallel imaging and with acceleration
factor two and four. It can clearly be seen that the SNR in
the image decreases with increasing acceleration factor.
However, the SNR loss does not radically affect tissue seg-
mentation as can be seen in figure 2. Even the difficult
regions to depict of the basal ganglia are successfully seg-
mented after image acquisition using acceleration factor
four.
Table 2: Summary of the image processing procedures using BMAP/Volstat and BET/Sienax.
BMAP/Volstat (In-house) BET/Sienax (FSL)
Original images T1 MPRAGE T1 MPRAGE and T2 SPACE
Process Registration to reference brain
(9 parameter)
Registration to reference brain
(12 parameter)
Output T1 in standard space T1 and T2 in standard space
Process Brain masking using BMAP
(cortical CSF (ICV) contour based on T1)
(stepwise region growing algorithm)
Brain masking using BET
(cortical CSF (ICV) contour based on T2)
(brain contour fitting algorithm)
Output T1 brain (ICV) T1 brain (ICV)
Process Tissue segmentation (Volstat – Fuzzy c-means cluster analysis) Tissue segmentation (Sienax- Random Markov Fields)
Final output Grey-, white- and CSF-cluster images Grey-, white- and CSF-cluster images
The key image processing steps are outlined for registration to standard space, masking of non intra-cranial volume (ICV) tissue and tissue 
segmentation.
MPRAGE images acquired without parallel imaging Figure 1
MPRAGE images acquired without parallel imaging. 
Images are acquired with acceleration factor two and accel-
eration factor four (columns left to right) in each of three 
perpendicular planes. The sagital direction was that acquired, 
which was reformatted to the coronal orientation for evalua-
tion of hippocampus measurements and axial orientation for 
completion.BMC Medical Imaging 2009, 9:15 http://www.biomedcentral.com/1471-2342/9/15
Page 6 of 10
(page number not for citation purposes)
GM, WM and CSF volumes were measured using both
evaluation software packages. The brain parenchyma frac-
tion (BPF) was then calculated. The 18 datasets were
grouped according to acceleration factor (without, factor
two and factor four) and the mean tissue volume, stand-
ard deviation (SD) and coefficient of variation (CoV) were
calculated for each group. The descriptive statistics of the
repeated scanning of the young healthy volunteer are pre-
sented in table 3.
It is seen that tissue volumes measured with acceleration
factor two are remarkably similar to those measured with-
out the application of parallel imaging. However, a more
significant change in absolute tissue volumes is observed
with the use of acceleration factor four. This is true for
brain volumes measured using both evaluation software
packages. However, the differences seen using BMAP are
considerably smaller than those seen when using Sienax.
Moreover, BMAP volumes acquired using acceleration fac-
tor two are within 1 SD of the volumes measured without
GRAPPA applied whereas volumes measured using Sienax
are within 2 SD. Greater deviations in absolute volumes
are observed when using images acquired with accelera-
tion factor four with the exception of GM evaluated using
BMAP which is within 1 SD. These differences may be due
to a difference in tissue classification as a result of the
reduced SNR and/or contrast with increasing acceleration.
BMAP appears to be less sensitive to such changes, which
is likely due to the calculation of fuzzy volumes as
opposed to crisp volumes.
Despite the systematic difference in measured volumes
using parallel imaging, the tissue volumes are all meas-
ured consistently with small coefficients of variation
which does not increase with increasing acceleration fac-
tor. This is a critical property for use in longitudinal volu-
metric studies. Analysis using the BET/Sienax program
results in a CoV based on the six repeated scans of 0.5% at
most for BPF, 3.2% for CSF volume and in the order of 1%
for GM and WM volumes. Surprisingly, even the use of
A transaxial slice of the brain Figure 2
A transaxial slice of the brain. The top left image is of a 
single transaxial slice acquired with an MPRAGE without par-
allel imaging. The top right image is the same slice post seg-
mentation and crisp volumes of CSF, grey matter and white 
matter are represented by dark gray, light grey and white 
regions. The bottom row shows the same slice crisp volumes 
resulting fro segmentation of MPRAGE images acquired using 
iPAT acceleration factors 2 and 4 (left and right respectively).
Table 3: Descriptive statistics of brain tissue volumes of a young 
healthy volunteer scanned 6 times at several acceleration (iPAT) 
factors.
BET/Sienax BMAP/Volstat
Volume iPAT Mean SD CoV Mean SD CoV
BPF 0 82.9% 0.3% 0.3% 80.7% 0.3% 0.3%
2 82.3% 0.4% 0.5% 80.6% 0.2% 0.3%
4 82.4% 0.3% 0.4% 78.1% 0.3% 0.3%
GM 0 823 7.6 0.9% 786 4.2 0.5%
2 817 6.5 0.8% 786 2.8 0.4%
4 756 4.0 0.5% 781 2.8 0.4%
WM 0 539 8.5 1.6% 483 3.2 0.7%
2 553 5.0 0.9% 485 3.8 0.8%
4 635 3.3 0.5% 452 6.1 1.3%
CSF 0 281 7.3 2.6% 304 4.4 1.4%
2 294 9.5 3.2% 305 3.3 1.1%
4 298 7.1 2.4% 345 4.2 1.2%
Volumes were measured using the BET and Sienax algorithms of FSL 
in addition to the BMAP/Volstat in-house software. Volumes are in 
cm3 with the exception of BPF, which is unitless.BMC Medical Imaging 2009, 9:15 http://www.biomedcentral.com/1471-2342/9/15
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acceleration factor four produces tissue volumes with as
repeatable measurement as that without the use of paral-
lel imaging.
Analysis using BMAP/Volstat results in even smaller CoV
in measurement based on the six repeated scans: 0.3% for
BPF, approximately 0.5% for GM and in the order of 1%
for CSF and WM volumes. Such precision in measurement
indicates that volumes changes over time will be detecta-
ble.
Elderly patient group
All data acquired with parallel imaging acceleration fac-
tors two and four were free from motion artefacts and
could be used for volumetric analysis. The total and seg-
mented brain tissue volumes were measured using the
two evaluation programs for each of the volunteers. The
3D T2-weighted images were successfully used for brain
masking in BET. Of the 15 elderly patients who under-
went repeated scanning on a second occasion, two MCI
patients were unintentionally not scanned using accelera-
tion factor four.
Tissue volumes for all 15 patients were measured and the
mean, standard deviation and coefficient of variation
were calculated for the entire patient group and presented
in table 4. This was performed separately for each acceler-
ation factor on the two separately acquired datasets allow-
ing comparisons to be made between repeated scans of
the same elderly patient and different acceleration factors.
In agreement with the results from the young healthy vol-
unteer, the standard deviation and CoV do not increase
with increasing acceleration factor. There is however, as
seen in the young healthy volunteer, a systematic differ-
ence in absolute volumes.
An intraclass correlation test (ICC) was used to further
analyse these results and are presented in table 5. ICC
coefficients of greater than 0.95 resulted for both BPF and
segmented tissue volumes independent of the volumetric
software package used. These results indicate that volumes
can be considered almost identical. This is true for data
sets acquired with parallel imaging acceleration factor two
and four.
A comparison of the volumes measured at the two differ-
ent acceleration factors could also be made for 13
patients. Data was grouped according to acceleration fac-
tor and compared using the ICC. Results presented in
Table 4: Descriptive statistics of repeatedly scanned patient brain volumes.
BET/Sienax BMAP/Volstat
iPAT scan BPF GM WM CSF BPF GM WM CSF
2 1 Mean 72.9% 662 504 432 73.5% 657 417 386
2 2 Mean 73.2% 664 507 427 73.6% 656 419 385
4 1 Mean 73.2% 596 564 425 75.5% 670 448 361
4 2 Mean 73.0% 596 562 428 75.4% 670 444 363
2 1 SD 3.8% 77 61 57 2.7% 71 53 45
2 2 SD 4.2% 78 54 69 3.0% 71 50 55
4 1 SD 4.1% 62 62 72 2.8% 60 50 55
4 2 SD 3.9% 61 57 70 2.9% 59 51 56
2 1 CoV 0.5% 11.6% 12.0% 13.2% 0.4% 10.6% 11.2% 15.1%
2 2 CoV 0.6% 11.7% 10.8% 16.1% 0.4% 10.5% 11.7% 12.5%
4 1 CoV 0.6% 10.4% 10.9% 16.9% 0.4% 9.2% 11.9% 14.3%
4 2 CoV 0.5% 10.2% 10.2% 16.3% 0.4% 9.0% 12.1% 14.6%
Data of 15 patient images are included in the acceleration factor two comparison and of 13 patients in the acceleration factor four comparison. 
Volumes were measured using the BET and Sienax algorithms of FSL in addition to the BMAP/Volstat in-house software. Volumes are measured in 
cm3 with the exception of BPF, which is unitless.BMC Medical Imaging 2009, 9:15 http://www.biomedcentral.com/1471-2342/9/15
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table 6 indicate an almost perfect agreement between the
volumes measured with ICC coefficients over 0.82 for all
tissue volumes and BPF when measured using BMAP/Vol-
stat. Results for BPF and CSF measured using BET/Sienax
were particularly excellent with ICC coefficients greater
than 0.97. However, such perfect agreement was not
measured for all tissue classes. The GM and WM ICC coef-
ficients were 0.737 and 0.543 respectively indicating only
reasonable agreement.
Hippocampus volumes were also measured in all 15 eld-
erly patients. Measurements were made by manually out-
lining the region on the images acquired with acceleration
factor two. The same operator performed all measure-
ments.
Repeated measurements of both left and right hippoc-
ampi volumes on the same data resulted in an ICC of
0.965 indicating almost identical repeated measurements.
This shows that the operator error is exceeding low. Vol-
umes measured on data acquired on two separate occa-
sions were also compared. An ICC of 0.884 resulted,
indicating almost perfect agreement in the measurements.
Discussion
The aim of this study was to investigate if parallel imaging
may be a useful technique to shorten image acquisition
time in high-resolution volumetric investigations of
dementia patients. The authors are not aware of parallel
imaging previously being tested for use in volumetric MRI
studies. This is particularly important since elderly
patients often have difficulties to keep still long enough to
acquire such high-resolution images often resulting in
poor image quality acquisitions. Today this is solved by
repeating the acquisition and hoping for better coopera-
tion. In fact, in the ADNI protocol the MPRAGE sequence
is acquired twice in the hope that at least one image is free
from motion artefacts.
A group of 15 elderly patients including healthy controls,
those diagnosed with mild cognitive impairment and
Alzheimer's disease underwent MRI examinations to
acquire high-resolution images using the GRAPPA parallel
imaging technique. All patients were successfully exam-
ined and resulting images were artefact free. Image acqui-
sition times were shortened from approximately 7.5
minutes to 3.5 minutes.
The increased number of clinical trials regarding sympto-
matic and disease modifying drugs highlights a need to
monitor not only healthy elderly controls but also more
severely affected AD patients. Such patients are often the
most uncooperative and are unable to remain still for the
prolonged periods required for an MRI examination. Typ-
ical existing imaging protocols often include high-resolu-
tion 3D images that are time consuming to acquire (8–10
mins). These long scan times lead to a higher risk of such
patients moving during acquisition causing motion arte-
facts that prevent volumetric analysis from being per-
formed. This leads to a rejection or dropout of patients
who are severely affected by neurodegenerative diseases
and thereby leading to a possible biasing of clinical data
towards patients in the earlier stages of the disease. Thus,
the need for short acquisition times is paramount to
ensuring comprehensive volumetric data can be collected
that is representative of the complete spectrum of demen-
tia patients. The protocol presented here with the applica-
tion of GRAPPA acceleration factor 2 would reduce the
scan time in half which would likely result in a reduced
drop out rate of patients in AD studies and clinical drug
trials.
Table 5: Intraclass correlation (class 1) results of BPF and 
segmented tissue volumes.
iPAT Tissue ICC (Sienax) ICC (Volstat)
2 BPF 0.955 0.971
2 GM 0.997 0.994
2 WM 0.958 0.961
2 CSF 0.967 0.975
4 BPF 0.993 0.988
4 GM 0.976 0.996
4 WM 0.962 0.983
4 CSF 0.992 0.994
The brain volumes were measured using patient images acquired on 
two separate occasions with the same acceleration factor. Data of 15 
patient images are included in the acceleration factor two comparison 
and of 13 patients in the acceleration factor four comparison. 
Volumes were measured using the BET-Sienax algorithms of FSL 
(ICC(Sienax)) and BMAP-Volstat program (ICC(Volstat)). Volumes 
are measured in cm3 with the exception of BPF, which is unitless.
Table 6: Intraclass correlation (class 1) results comparing 13 
patient brain tissue volumes.
Tissue ICC (Sienax) ICC (Volstat)
BPF 0.970 0.827
GM 0.737 0.985
WM 0.543 0.878
CSF 0.977 0.882
The volumes compared were measured from images acquired at 
acceleration factors two and four using the two analysis programs 
investigated.BMC Medical Imaging 2009, 9:15 http://www.biomedcentral.com/1471-2342/9/15
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The results presented here indicate that parallel imaging
can indeed be used for high-resolution (1.3 × 1.3 × 1.3
mm) image acquisition at 1.5 T without hampering auto-
matic or manual volumetric segmentation methods. It is
apparent from the descriptive statistics presented in table
4 that the imaging protocol with parallel imaging can be
reliably used to measure brain-tissue volumes in the eld-
erly patient group. Two volumetric analysis software pro-
grams have been used to evaluate all data. Repeated
measurements of tissue volumes made using images
acquired on two separate occasions are almost identical
with ICC coefficients of greater than 0.95 (table 5) for all
tissue classes independent of the software used for volu-
metric analysis.
The BPF appears unchanged with the application of
GRAPPA acceleration factor two compared to the use of
no parallel imaging (tables 3 and 4). This is true inde-
pendent of the software choice for volumetric analysis. In
fact, the BPF appears essentially unchanged even with the
application of acceleration factor four when segmentation
was performed using Sienax (tables 3 and 4). ICC tests
comparing BPF measured with parallel imaging factors
two and four evaluated with Sienax result in a coefficient
of 0.970 (table 6). The coefficient of variation in repeated
measurement of the BPF in the same volunteer was no
greater than 0.5% for all acceleration factors investigated
and is independent of the software used.
However, absolute tissue volumes appear to change with
parallel imaging acceleration factor as presented in tables
3 and 4 and compared in table 6. This is attributed to the
increase in image noise, which affects the SNR and image
contrast and thereby the tissue classification algorithms.
The Sienax algorithm appears to consistently measure CSF
volume as the acceleration factor is increased but the dis-
tribution of grey and white matter changes. Thus, the BPF
remains constant. Whereas, the Volstat software appears
to consistently measure GM volume but that of WM and
CSF changes marginally when using acceleration factor
four, thereby affecting the BPF. Further study is necessary
to investigate the mechanism of this effect paying particu-
lar attention to the non-uniform noise distribution
throughout the images.
There is also, as expected, some difference observed in the
absolute brain tissue volumes measured when images
were analysed with different software (tables 3, 4). The
BMAP software includes cortical CSF whereas the BET
software includes only internal CSF. Thus, the BPF meas-
ured with Volstat is smaller than that measured using
Sienax. The method of tissue classification is also signifi-
cantly different and accounts for the differences measured
in tissue volumes. Namely, Sienax measured crisp vol-
umes whilst Volstat measured fuzzy volumes after weight-
ing the signal intensity distribution according to the
spread in signal intensity peaks. Previously published
work [12] has shown that different volumetric software
used to evaluate the same images result in different abso-
lute tissue volumes. The figure of merit however, when
comparing volumetric tools, is that of reproducibility in
measurement. Both software tested in this study handled
the parallel imaging data successfully with high repeata-
bility in measurement (table 5), although T2-weighted
images were required to successfully mask the brain when
using the BET algorithm of FSL. Since these images are
acquired as part of the routine examination this is not
considered a problem.
Images acquired using GRAPPA parallel imaging factor
two were used to manually outline the hippocampus of
all elderly patients. Hippocampi volumes were measured
using two images of the same patient and ICC tests indi-
cate almost perfect agreement in measurements. This indi-
cates that despite the reduced SNR in the centre of the
image, parallel imaging with acceleration factor 2 does
not hinder the manual measurement of hippocampus
volumes in elderly patients in longitudinal studies which
is also of importance in the study of Alzheimer's disease
progression.
Further studies are planned to examine the elderly patient
group again which will be more approximately two years
after the initial examinations. The effect the parallel imag-
ing factor has on the measured BPF change will be inves-
tigated.
Conclusion
In summary, these results indicate that at 1.5 T and a res-
olution of 1.3 × 1.3 × 1.3 mm parallel imaging can be used
without detrimental effect to brain tissue segmentation
and volumetric measurement of global and regional tissue
volumes. The acquisition time for the necessary high-res-
olution T1-weighted scan can be reduced by almost a fac-
tor of two. In this study, all patients were examined
without the need to repeat any acquisition due to patient
movement. Those designing the imaging protocol for lon-
gitudinal volumetric studies should consider the applica-
tion of parallel imaging from the outset. This may allow
easier recruitment of many patients into the study and
minimise the drop-out rate over the duration of the study
as patient health deteriorates with age.
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